**16. References**


Preclinical and Predictive Algorithms in Monitoring

(November 2008) ISSN 685-96

(November 2008) ISSN 685-96

No.4 (May 2010) ISSN 315-8

IMAJ Vol.6 (July 2004); 6:433-435

2001) ISSN E112

ISSN 417-9

e1000024

e1000024

Patients with Autoimmune Diseases and Their Relatives-at-Risks 217

De Block, C.E.; De Leeuw, I.H. & Van Gaal, L.F. (1999) High prevalence of manifestations of

Dendrou, C.A. & Wicker, L.S. (2008) The IL-2/CD25 pathway determines susceptibility to

DeStefano, F.; Mullooly, J.P. & Okoro, C.A. et al (2001) Childhood vaccinations, vaccination

Dorman, J.S.; Steenkiste, A.R.; Burke, J.P. & Songini, M. (2003) Type 1 diabetes and multiple sclerosis: together at last. Diabetes Care, Vol.26, No.11 (2003) ISSN 3192-3 Douroudis K, Shcherbakova A, Everaus H, Aints A.; PTPN22 gene regulates natural killer cell proliferation during *in vitro* expansion.; Tissue Antigens. 2010 May 30 Douroudis, K.; Nemvalts, V.; Rajasalu, T.; Kisand, K. & Uibo, R. (2009) The CD226 gene in

Douroudis, K.; Shcherbakova, A.; Everaus, H. & Aints, A. (2010) PTPN22 gene regulates

Downes, K.; Pekalski, M.; Angus, K.L.; Hardy, M.; Nutland, S.; Smyth, D.J.; Walker, N.M.;

Faideau, B.; Larger, E.; Lepault, F.; Carel, J.C. & Boitard. C. (2005). Role of β-Cells in Type 1 Diabetes Pathogenesis. Diabetes, Vol. 54, No.2, (December 2005) ISSN S87-S96 Favorova, O.O.; Kulakova, O.G. & Boĭko, A.N. (2010) Multiple sclerosis as a polygenic disease: an update. Genetika, Vol.46, No.3 (March 2010) ISSN 302-13 Fernando, MM.; Stevens, CR.; Walsh, EC.; De Jager, PL.; Goyette, P.; Plenge, RM.; Vyse, TJ.

Fernando, MM.; Stevens, CR.; Walsh, EC.; De Jager, PL.; Goyette, P.; Plenge, RM.; Vyse, TJ.

Ferreira, R.C.; Pan-Hammarström, Q.; Graham, R.R.; Gateva, V.; Fontán, G.; Lee, A.T.;

gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. The Journal of clinical endocrinology and metabolism, Vol.84, No.11 (November 1999) ISSN 4062-7 Dendrou, C.A. & Wicker, L.S. (2008) The IL-2/CD25 pathway determines susceptibility to

T1D in humans and NOD mice. Journal of clinical immunology, Vol.28, No.6

T1D in humans and NOD mice. Journal of clinical immunology, Vol.28, No.6

timing and risk of type 1 diabetes mellitus. Pediatrics, Vol.108, No.6 (December

susceptibility of type 1 diabetes. Tissue Antigens, Vol.74, No.5 (November 2009)

natural killer cell proliferation during in vitro expansion. Tissue antigens, Vol.76,

Wallace, C. & Todd, J.A. (2010) Reduced expression of IFIH1 is protective for type 1 diabetes. Public Library of Science one, Vol.5, No.9 (September 2010) ISSN e12646 Essien, A.D. & Akpan, J.O. (2006) Diabetogenic property of charred meat on litters of

pregnant albino rats. Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria, Vol.21, No.1-2 (June 2006) ISSN 37-41 Ethan Rubinstein MD (2004) Vaccination and Autoimmune Diseases: the Argument Against.

& Rioux, JD. (2008). Defining the role of the MHC in autoimmunity: a review and pooled analysis. Public Library of Science genetics, Vol.4, No.4, (April 2008), ISSN

& Rioux, JD. (2008). Defining the role of the MHC in autoimmunity: a review and pooled analysis. Public Library of Science genetics, Vol.4, No.4, (April 2008), ISSN

Ortmann, W.; Urcelay, E.; Fernández-Arquero, M.; Núñez, C.; Jorgensen, G.; Ludviksson, B.R.; Koskinen, S.; Haimila, K.; Clark, H.F.; Klareskog, L.; Gregersen, P.K.; Behrens, T.W. & Hammarström, L. (2010) Association of IFIH1 and other


Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan

of type 1 diabetes. Nat Genet. 2009 Jun;41(6):703-7. (Epub 2009) May 10. Blom, L.; Nystron, L. & Dahlquist, G. (1991) The Swedish childhood diabetes study:

Bougnères, P. & Valleron, A.J. (2008) Causes of early-onset type 1 diabetes: toward data-

Bussone, G. & Mouthon, L. (2009) Autoimmune manifestations in primary immune deficiencies. Autoimmunity reviews, Vol.8, No.4 (February 2009) ISSN 332-6 Buzzetti, R.; Di Pietro, S.; Giaccari, A.; Petrone, A.; Locatelli, M.; Suraci, C.; Capizzi, M.;

Cantor, J. & Haskins, K. (2007) Recruitment and activation of macrophages by pathogenic

Cherian, M.P.; Al-Kanani, K.A.; Al Qahtani, S.S.; Yesurathinam, H.; Mathew, A.A.; Thomas,

Chistiakov, D.A.; Voronova, N.V. & Chistiakov, P.A. (2008) The crucial role of IL-2/IL-2RA-

Classen, J.B. & Classen, D.C. (1999) Association between type 1 diabetes and Hib vaccine:

Concannon, C.; Rich, S.S. & Nepom, G.T. (2009) Mechanisms of Disease Genetics of Type 1A

Dahlquist, G.G.; Blom, L.G.; Persson, L.A.; Sandström, A.I. & Wall, S.G. (1990) Dietary

Darrasse-Jèze, G.; Deroubaix, S.; Mouquet, H.; Victora, G.D.; Eisenreich, T.; Yao, K.H.;

Diabetes. The new england journal o f medicine, (April 2009)

(Clinical research ed.), Vol.300, No.6735 (May 1990) ISSN 1302-6

Journal of immunology, Vol.179, No. 9 (November 2007) ISSN 5760-7 Catherine Pihoker, Lisa K. Gilliam, Christiane S. Hampe and Åke Lernmark; Auto-Abs in

Diabetologica, Vol.34, No.3 (March 1991) ISSN 176-81

Diabetes. Diabetes. 2005 Dec;54 Suppl 2:S52-61.

and metabolism, Vol.23, No.7 (July 2010) ISSN 685-95

No.13 (December 2008) ISSN 2953-7

No.4 (April 2007) ISSN 932-8

(June 2008) ISSN 1-5

1999) ISSN 1133

G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS; Type 1 Diabetes Genetics Consortium (2009). Genome-wide association study and meta-analysis find that over 40 loci affect risk

vaccinations and infections as risk determinants for diabetes in childhood.

driven environmental approaches. The Journal of experimental medicine, Vol.205,

Arpi, M.L.; Bazzigaluppi, E.; Dotta, F. & Bosi, E. (2007) Non Insulin Requiring Autoimmune Diabetes Study Group; High titers of auto-Abs to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care, Vol.30,

CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1.

V.S.; Mathew, A.M. & Abduljabbar, M.A. (2010) The rising incidence of type 1 Diabetes mellitus and the role of Environmental Factors - three Decade experience in a Primary health care center in Saudi Arabia. Journal of pediatric endocrinology

mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies. Immunology letters, Vol.118, No.1

causal relations is likely. BMJ (Clinical research ed.), Vol.319, No.7217 (October

factors and the risk of developing insulin dependent diabetes in childhood. BMJ

Masilamani, R.F.; Dustin, M.L.; Rudensky, A.; Liu, K. & Nussenzweig, M.C. (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. The Journal of experimental medicine, Vol.206, No.9 (August 2009) ISSN 1853-62 Darrasse-Jèze, G.; Deroubaix, S.; Mouquet, H.; Victora, G.D.; Eisenreich, T.; Yao, K.H.;

Masilamani, R.F.; Dustin, M.L.; Rudensky, A.; Liu, K. & Nussenzweig, M.C. (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. The Journal of experimental medicine, Vol.206, No.9 (August 2009) ISSN 1853-62


autoimmunity risk alleles with selective IgA deficiency. Nature genetics, Vol.42, No.9 (September 2010) ISSN 777-80

Preclinical and Predictive Algorithms in Monitoring

2001) ISSN 387-94

8541-8

Vol.49, No.6 (June 2006) ISSN 1198-208

Patients with Autoimmune Diseases and Their Relatives-at-Risks 219

Hermann, R.; Lipponen, K.; Kiviniemi, M.; Kakko, T.; Veijola, R.; Simell, O.; Knip, M. &

Herrath, M.; Sanda, S. & Herold, K. (2007). Opinion Type 1 diabetes as a relapsing-remitting

Hilger, C.; Grigioni, F.; De Beaufort, C.; Michel, G.; Freilinger, J. & Hentges, F. (2001)

Hirasawa, K.; Jun, H.S.; Han ,H.S.; Zhang, M.L.; Hollenberg, M.D. & Yoon, J.W. (1999)

Hodgkinson, A.D.; Millward, B.A. & Demaine, A.G. (2000). The HLA-E locus is associated

Hoffmann, A. & Baltimore, D. (2006) Circuitry of nuclear factor kappaB signaling.

Hongjie Wang, Yulan Jin, M. V. Prasad Linga Reddy, Robert Podolsky, Siyang Liu, Ping

Howson, J.M.; Walker, N.M.; Clayton, D. & Todd, J.A. (2009) Confirmation of HLA class II

Hunger-Battefeld, W.; Fath, K.; Mandecka, A.; Kiehntopf, M.; Kloos, C.; Müller, U.A. &

Jiang, H.; Canfield, S.M.; Gallagher, M.P.; Jiang, H.H.; Jiang, Y.; Zheng, Z. & Chess. L. (2010).

Jun, H.S. & Yoon, J.W. (2001) The role of viruses in type I diabetes: two distinct cellular and

Kakleas, K.; Paschali, E.; Kefalas, N.; Fotinou, A.; Kanariou, M.; Karayianni, C. &

immunology, Vol.63, No.3 (March 2000), ISSN 290-5

PLoS One. 2010 Jul 26;5(7):e11789

No.3 (March 2009) ISSN 183-91

Vol. 120, No.10 (October 2010) ISSN 3641-50

Diabetologia, Vol.44, No.3 (March 2001) ISSN 271-85

2009) ISSN 31-45

(2009) ISSN 214-20

Immunological reviews, Vol.210 (April 2006) ISSN 171-86

Susceptibility in the General Population; December 2009 2835-2842

of Diabetes-Associated Auto-Abs Among Children With HLA-Conferred Disease

Ilonen, J. (2006) Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia,

desease? Nature reviews. Immunology. Vol.7, No.12, (December 2007), ISSN 988-94

Differential binding of IgG and IgA antibodies to antigenic determinants of bovine ser&um albumin. Clinical and experimental immunology, Vol.123, No.3 (March

Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages. Journal of virology, Vol.73, No.10 (October 1999) ISSN

with age at onset and susceptibility to type 1 diabetes mellitus. Human

Yang, Bruce Bode, John Chip Reed, R. Dennis Steed, Stephen W. Anderson, Leigh Steed, Diane Hopkins, Yihua Huang, Jin-Xiong She. Genetically Dependent ERBB3 Expression Modulates Antigen Presenting Cell Function and Type 1 Diabetes Risk

independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes, obesity & metabolism, Suppl 1, (February

Wolf, G. (2009) [Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1]. [Article in German] Medizinische Klinik, Vol.104,

HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. The Journal of clinical investigation,

molecular pathogenic mechanisms of virus-induced diabetes in animals.

Karavanaki, K. (2009) Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Upsala journal of medical sciences, Vol.114, No.4


Fichna, M.; Zurawek, M.; Januszkiewicz-Lewandowska, D.; Fichna, P. & Nowak, J. (2010)

Fourlanos, S.; Varney, M.D.; Tait, B.D.; Morahan, G.; Honeyman, M.C.; Colman, P.G. &

Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, Drew JC, Ilonen J, Knip

Giongo, A.; Gano, K.A.; Crabb, D.B.; Mukherjee, N.; Novelo, L.L.; Casella, G.; Drew, J.C.;

Giuliani, L.; Mele, R.; Di Giovine, M.; Altieri, L.; Crinò, A.; Ravà, L. & Fierabracci. A. (2009)

Grey, S.T.; Longo, C.; Shukri, T.; Patel, V.I.; Csizmadia, E.; Daniel, S.; Arvelo, M.B.;

Hafler, J.P.; Maier, L.M.; Cooper, J.D.; Plagnol, V.; Hinks, A.; Simmonds, M.J.; Stevens, H.E.;

Hayashi, T.; Hasegawa, K.; Morimoto, M. & Onodera, T. (2003) Effect of antibodies to

Hayashi, T.; Morimoto, M.; Iwata, H. & Onodera, T. (1998) Interferon-gamma plays a role in

Heli T.A. Siljander, Satu Simell, Anne Hekkala, Jyrki Lähde, Tuula Simell, Paula Vähäsalo,

diseases. Genes and immunity, Vol.10, No.1 (January 2009) ISSN 5-10 Hanifi-Moghaddam, P.; Schloot, N.C.; Kappler, S.; Seissler, J. & Kolb, H. (2003) An

patients. Journal of biomedicine & biotechnology, (2009) ISSN 576219 Green, E.A.; Eynon, E.E. & Flavell, R.A. (1998) Local expression of TNFalpha in neonatal

1 diabetes. ISME J. 2011 Jan;5(1):82-91. Epub 2010 Jul 8

Immunity, Vol.9, No.5 (November 1998) ISSN 733-43

Vol.170, No.12 (June 2003) ISSN 6250-6

Vol.128, No.4 (May 2003) ISSN 283-8

No.5 (October 1998) ISSN 313-20

Diabetes, Vol.52, No.5 (May 2003) ISSN 1137-42

No.9 (September 2010) ISSN 777-80

(October 2010) ISSN 367-72

(January 2011) ISSN 82-91

No.8 (August 2008) ISSN 1546-9

autoimmunity risk alleles with selective IgA deficiency. Nature genetics, Vol.42,

PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. International journal of immunogenetics, Vol.37, No.5

Harrison, L.C. (2008) The rising incidence of type 1 Diabetes is accounted for by cases with Lower-Risk Human leukocyte Antigen genotypes. Diabetes Care, Vol.31,

M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, Schatz D, Atkinson MA, Triplett EW.; Toward defining the autoimmune microbiome for type

Ilonen, J.; Knip, M.; Hyöty, H.; Veijola, R.; Simell, T.; Simell, O.; Neu, J.; Wasserfall, C.H.; Schatz, D.; Atkinson, M.A. & Triplett, E.W. (2011) Toward defining the autoimmune microbiome for type 1 diabetes. The ISME journal, Vol.5, No.1

Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic

NOD mice promotes diabetes by enhancing the presentation of islet antigens.

Tchipashvili, V. & Ferran, C. (2003). Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. The Journal of immunology,

Walker, N.M.; Healy, B.; Howson, J.M.; Maisuria, M.; Duley, S.; Coleman, G. & Gough, S.C. (2009) CD226 Gly307Ser association with multiple autoimmune

Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes.

intercellular adhesion molecule (ICAM)-1 and lymphocyte function-associated antigen (LFA)-1 on cytokine mRNA expression in reovirus type-2-triggered autoimmune insulitis in suckling DBA/1 mice. Journal of comparative pathology,

pancreatic islet-cell destruction of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice. International journal of experimental pathology, Vol.79,

Riitta Veijola, Jorma Ilonen, Olli Simell and Mikael Knip; Predictive Characteristics

of Diabetes-Associated Auto-Abs Among Children With HLA-Conferred Disease Susceptibility in the General Population; December 2009 2835-2842


Preclinical and Predictive Algorithms in Monitoring

(February 2008) ISSN 698-707

(December 2002) ISSN 4809-19

Vol.41, No.1 (January 2998) ISSN 72-8

ISSN 2972-9

ISSN 2975-84

Patients with Autoimmune Diseases and Their Relatives-at-Risks 221

Noble, J.A.; Valdes, A.M.; Varney, M.D.; Carlson, J.A.; Moonsamy, P.; Fear, A.L.; Lane, J.A.;

Oresic, M.; Simell, S.; Sysi-Aho, M.; Näntö-Salonen, K.; Seppänen-Laakso, T.; Parikka, V.;

Qu, H.Q. & Polychronakos, C. (2009). The effect of the MHC locus on autoantibodies in type 1 diabetes. Journal of medical genetics, Vol.46, No.7 (July 2009), ISSN 469-71 Rajasalu, T.; Haller, K.; Salur, L.; Kisand, K.; Tillmann, V.; Schlosser, M. & Uibo, R. (2007)

Riachy, R.; Vandewalle, B.; Kerr Conte, J.; Moerman, E.; Sacchetti, P.; Lukowiak, B.; Gmyr,

Saukkonen, T.; Virtanen, S.M.; Karppinen, M.; Reijonen, H.; Ilonen, J.; Räsänen, L.;

Sepiashvili R.I., Kimova M.V., Kalinina E.V., Martinov L.A., D.S. Kostyushev., Y.Shoenfeld,

Severinski, S.; Banac, S.; Severinski, N.S.; Ahel, V. & Cvijović, K. (2009) Epidemiology and

general population. Diabetes, Vol. 58, No.12 (December 2009) ISSN 2835-42 Solomon, M.; Balasa, B. & Sarvetnick, N. (2010) CCR2 and CCR5 chemokine receptors

Somers, E.C.; Thomas, S.L.; Smeeth, L. & Hall, A.J. (2009) Are individuals with an

Suchkov.; L.A. Martynov.; I.A. Vinokurov.; D.S. Kostyushev.; A.A. Andreeva.; S.I.

diseases. Allergology and Immunology.; Vol. 11 No.1 pp. 20-30

mouse. Autoimmunity, Vol.43, No.2 (March 2010) ISSN 156-63

journal of epidemiology, Vol.169, No.6 (March 2009) ISSN 749-55

research and reviews, Vol.23, No.7 (October 2007) ISSN 567-71

standardization program sample subset. Journal of proteome research, Vol.7, No.2

Lavant, E.; Rappner, R.; Louey, A.; Concannon, P.; Mychaleckyj, J.C. & Erlich, H.A. (2010). HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes, Vol.59, No.11 (November 2010),

Katajamaa, M.; Hekkala, A.; Mattila, I.; Keskinen, P.; Yetukuri, L.; Reinikainen, A.; Lähde, J.; Suortti, T.; Hakalax, J.; Simell, T.; Hyöty, H.; Veijola, R.; Ilonen, J.; Lahesmaa, R.; Knip, M. & Simell, O. (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. The Journal of experimental medicine, Vol.205, No.13 (December 2008)

Insulin VNTR I/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes. Diabetes/metabolism

V.; Bouckenooghe, T.; Dubois, M. & Pattou, F. (2002). 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology. Vol.143, No.12

Akerblom, H.K. & Savilahti, E. (1998) Significance of cow's milk protein antibodies as risk factor for childhood IDDM: interactions with dietary cow's milk intake and HLA-DQB1 genotype . Childhood Diabetes in Finland Study Group. Diabetologia,

Suchkov S.V (2010) Antibodies in the pathogenesis of demyelinating autoimmune

clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes. Collegium antropologicum, Vol.33, No.1 (March 2009) ISSN 273-9 Siljander, H.T.; Simell, S.; Hekkala, A.; Lähde, J.; Simell, T.; Vähäsalo, P.; Veijola, R.; Ilonen,

J.; Simell, O. & Knip, M. (2009) Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the

differentially influence the development of autoimmune diabetes in the NOD

autoimmune disease at higher risk of a second autoimmune disorder? American

Gadzhieva.; D.A. Gnatenko.; Y. Shoenfeld.; Y.M. Lopuhin.; A. Notkins.; M.A.


Karvonen, M.; Cepaitis, Z. & Toumilheto, J. (1999) Association between type 1 diabetes and

Katona-Dureković, A. (2007) The role of virus infections in the pathogenesis of type 1

Kawasaki, E.; Nakamura, K.; Kuriya, G.; Satoh, T.; Kuwahara, H.; Kobayashi, M.; Abiru, N.;

endocrinology and metabolism, Vol. 95, No.2 (February 2010) ISSN 707-13 Kim, S.J.; Jeong, D.G.; Jeong, S.K.; Yoon, T.S. & Ryu, S.E. (2007) Crystal structure of the major

Kohno, T.; Kobashiri, Y.; Sugie, Y.; Takai, S.; Watabe, K.; Kaino, Y. & Kida, K. (2002)

Diabetes research and clinical practice, Vol.55, No.1 (January 2002) ISSN 1-9 Kordonouri, O.; Hartmann, R.; Charpentier, N.; Knip, M.; Danne, T. & Ilonen, J. (2010)

Lee, M.H.; Lee, W.H.; Todorov, I. & Liu, C.P. (2010) CD4+ CD25+ regulatory T cells prevent

Lipponen, K.; Gombos, Z.; Kiviniemi, M.; Siljander, H.; Lempainen, J.; Hermann, R.; Veijola,

Liu, Y.; Stanford, S.M.; Jog, S.P.; Fiorillo, E.; Orrú, V.; Comai, L. & Bottini, N. (2009)

Liuwantara, D.; Elliot, M.; Smith, M.W.; Yam, A.O.; Walters, S.N.; Marino, E.; McShea, A. &

Martinov L.A., Salafet O.V., Kimova M.V., O. Neuhaus., Y. Shoenfeld., M.A. Paltsev., S.V.

Mayr, A.; Schlosser, M.; Grober, N.; Kenk, H.; Ziegler, A.G.; Bonifacio, E. & Achenbach, P.

Metz, T.O.; Qian, W.J.; Jacobs, J.M.; Gritsenko, M.A.; Moore, R.J.; Polpitiya, A.D.; Monroe,

research ed.), Vol.318, No.7192 (May 1999) ISSN 1169-72

epitopes. Diabetes, Vol.56, No.1 (January 2007) ISSN 41-8

diabetes, Vol.116, No.4 (April 2010) ISSN 245-9

(August 2010) ISSN 2493-501

ISSN 3253-6

ISSN 7525-32

(February 2010) pp. 47-52

No.6 (June 2007) ISSN 1527-33

Haemophilus influenza type B vaccination: birth cohort study. BMJ (Clinical

diabetes--a case report. Medicinski pregled, Vol.60, No.7-8 (July 2007) ISSN 397-400

Yamasaki, H. & Eguchi. K. (2010) Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. The Journal of clinical

diabetes autoantigen insulinoma-associated protein 2 reveals distinctive immune

Antibodies to food antigens in Japanese patients with type 1 diabetes mellitus.

Genetic risk markers related to diabetes-associated auto-Abs in young patients with type 1 diabetes in berlin, Germany. Experimental and clinical endocrinology and

type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells. The Journal of immunology : official journal of the American Association of Immunologists, Vol.185, No.4

R.; Simell, O.; Knip, M. & Ilonen, J. (2010). Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes, Vol.59, No.12, (December 2010)

Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain. Biochemistry, Vol.48, No.31 (August 2009)

Grey, S.T. (2006) Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes, Vol. 55, No.9 (September 2006) ISSN 2491-501

Suchkov (2010) The demyelination phenomenon and control over its progression: basic preventive protocols of the future.; Efferent and physico-chemical medicine.;

(2007) GAD Autoantibody Affinity and Epitope Specificity Identify Distinct Immunization Profiles in Children at Risk for Type 1 Diabetes. Diabetes, Vol.56,

M.E.; Camp, D.G.; Mueller, P.W. & Smith, R.D. (2008) Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. Journal of proteome research, Vol.7, No.2 (February 2008) ISSN 698-707


Paltsev (2010) On the prospects of preclinical diagnostics within the objectives of preventive and predictive medicine. Efferent and Physico-Chemical medicine.; (March 2010)

**11** 

*Japan* 

**Application of Novel Quantitative Proteomic** 

**Technologies to Identify New Serological** 

Soyoung Lee, Satoshi Serada, Minoru Fujimoto and Tetsuji Naka *National Institute of Biomedical Innovation, Laboratory of Immune Signal* 

Autoimmune diseases comprise a wide variety of systemic or organ-specific inflammatory diseases, characterized by aberrant activation of immune cells that target self tissues due to misrecognizing tissue-derived proteins as foreign antigens (Hueber and Robinson, 2006; Prince, 2005). The prevalence of autoimmune diseases is approximately 2,000 ~ 3,000 per 100,000, although the prevalence varies depending on the diseases, ethnic groups and regions (Prieto and Grau, 2010). The etiology and exact pathogenesis of autoimmune diseases remain poorly understood. However, both genetic factors and environmental triggers are profoundly involved in the pathogenesis of autoimmune diseases. Notably, clinical manifestations of autoimmune disease may be different among patients, even though they have the same diagnosis, depending on the affected organs of each patient. Therefore, careful evaluation of the clinical manifestations combined with the examination of laboratory tests is required for proper diagnosis of autoimmune diseases and subsequent monitoring of the disease activity during therapy. In addition, therapeutic choices for these diseases have been limited so far and conventional therapeutics include non-steroidal antiinflammatory drugs (NSAID), glucocorticoids, cytotoxic drugs and disease modifying anti rheumatoid drugs (DMARDs). For these reasons, autoimmune diseases have been considered to be intractable and the goal of the treatment is to control disease activity rather

Recently, however, the advent of biological agents has led to the marked improvement in the treatment of rheumatoid arthritis (RA) and other inflammatory autoimmune diseases. These agents greatly contribute to improve health-related quality or daily life of patients with autoimmune diseases (Han et al., 2007; Keystone et al., 2008; Laas et al., 2009; Strand and Singh, 2007). Nevertheless, biological agents are not effective for all patients with autoimmune diseases and current biomarkers are not helpful to select an effective biological agent for individual patients. In addition, conventional inflammatory biomarkers are often inadequate to evaluate the disease activity in patients treated with biological agents. Thus, there is a growing need for the development of new biomarkers that can predict individual treatment response before starting biological therapy and evaluate the disease activity and therapeutic efficacy during therapy. In this chapter, we first outline the clinical usage and

**1. Introduction** 

than to achieve remission or cure.

**Biomarkers in Autoimmune Diseases** 

